wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33392585-D9255080-D36A-4E81-AD5A-7DFF93D0E59B
Q33392585-D9255080-D36A-4E81-AD5A-7DFF93D0E59B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33392585-D9255080-D36A-4E81-AD5A-7DFF93D0E59B
Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen.
P2860
Q33392585-D9255080-D36A-4E81-AD5A-7DFF93D0E59B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33392585-D9255080-D36A-4E81-AD5A-7DFF93D0E59B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c6b426682e69c5714da5f5aacabfbd4bc45bdde3
P2860
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lun